Cm Management, LLC Humanigen, Inc Transaction History

Cm Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$13.54 - $22.74 $338,500 - $568,500	-25,000 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$12.91 - $23.83 $193,650 - $357,450	-15,000 Reduced 37.5%	25,000 $478,000
Q4 2020 Feb 04, 2021	BUY	$7.97 - $21.66 $318,800 - $866,400	40,000 New	40,000 $700,000

558K

Ticker HGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,661,000
Description
Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called ?cytokine storm'. Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with...

Get notified when there are updates to the investment portfolio of Cm Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cm Management, LLC with notifications on news.